VIM and papillary renal cell carcinoma: Vimentin was positive in 53.9% cases of clear cell renal cell carcinoma, 80% cases of papillary renal cell carcinoma, focally positive in one case of chromophobe RCC and diffusely positive in another case of chromophobe RCC with sarcomatoid areas.